| Imidazole-containing alk2 kinase inhibitors |
2023-12-20 |
2024-1-15 |
|
| Bicyclic heteroaromatic klk5 inhibitors |
2023-11-10 |
2023-11-30 |
|
| Human plasma kallikrein inhibitor |
2023-11-06 |
2023-12-21 |
|
| Fusion protein inhibitors of klk5 |
2023-7-19 |
2024-1-25 |
|
| Imidazole-containing inhibitors of ALK2 kinase |
2023-4-03 |
2023-6-13 |
|
| Process-scale synthesis of a plasma kallikrein inhibitor. |
2023-3-30 |
2023-11-24 |
|
| Benzopyrazole compounds and analogues thereof |
2023-1-23 |
2023-7-13 |
|
| Synthesis of an antiviral azasugar triphosphate |
2023-1-23 |
2023-9-28 |
|
| Substituted benzofuran, benzopyrrole, benzothiophene and other structurally … |
2022-11-29 |
2023-7-21 |
|
| PYRROLOPYRIMIDINAMINES AS INHIBITORS OF THE COMPLEMENT SYSTEM |
2022-11-02 |
2022-12-30 |
|
| Complement factor d inhibitors for oral administration |
2022-5-09 |
2022-7-29 |
|
| COMPLEMENT FACTOR D INHIBITORS FOR ORAL ADMINISTRATION |
2022-5-06 |
2022-8-31 |
|
| Human plasma kallikrein inhibitors |
2022-3-10 |
2022-5-01 |
|
| DOSAGE REGIMES FOR ORAL COMPLEMENT FACTOR D INHIBITORS |
2022-2-24 |
2022-6-30 |
|
| Dosing regimens for oral alk2 kinase inhibitors |
2021-12-20 |
2022-6-30 |
|
| Methods and Compositions for Inhibition of Polymerase |
2021-10-21 |
2022-2-10 |
|
| TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA |
2021-10-08 |
2022-3-24 |
|
| Plasma kallikrein inhibitors and methods of use thereof in ocular disorders |
2021-10-07 |
2021-12-01 |
|
| Crystalline salts of a plasma kallikrein inhibitor |
2021-9-02 |
2022-6-30 |
|
| Methods of treating hematologic cancers |
2021-8-04 |
2022-2-10 |
|
| Antiviral treatments |
2021-7-21 |
2022-2-10 |
|
| Human plasma kallikrein inhibitor |
2021-7-15 |
2024-2-15 |
2024-2-15 |
| Methods, compositions, and dosing regimens for treatment of sars-cov-2 … |
2021-4-07 |
2023-5-25 |
|
| Methods and compositions for treatment of zika virus infection |
2021-3-01 |
2021-6-24 |
|
| Prodrugs of kallikrein inhibitors |
2020-8-07 |
2021-7-01 |
|
| Process-scale synthesis of a plasma kallikrein inhibitor. |
2020-8-05 |
2022-12-28 |
|
| DOSAGE REGIMES FOR ORAL COMPLEMENT FACTOR D INHIBITORS |
2020-7-31 |
2021-12-29 |
|
| Dosing regimens for oral complement factor D inhibitors. |
2020-7-29 |
2022-10-27 |
|
| Compositions and methods for inhibiting viral polymerases |
2018-1-19 |
2019-8-14 |
2019-8-14 |
| Antiviral azasugar-containing nucleosides |
2017-3-31 |
2017-9-21 |
|
| Anti-influenza compositions and methods |
2016-11-21 |
2017-5-18 |
|
| Intravenous antiviral treatments |
2016-11-21 |
2018-12-20 |
2018-12-20 |
| HUMAN PLASMA KALYKREIN INHIBITOR COMPOUNDS |
2016-9-30 |
2023-7-18 |
|
| Compositions comprising a plasma kallikrein inhibitor |
2016-8-24 |
2017-3-02 |
|
| Antiviral compounds, unit dosage form comprising said compounds and use thereof |
2016-1-14 |
2016-6-10 |
|
| Compositions and uses of amidine derivatives |
2015-8-24 |
2023-11-22 |
2023-11-22 |
| Method for producing amidine derivatives |
2015-8-24 |
2016-5-12 |
|
| COMPOSITIONS FOR USE IN THE TREATMENT OF VIRGIN INFECTIONS |
2015-5-29 |
2017-2-08 |
|
| Pyrazoles substituted with trifluoromethyl as inhibitors of human plasma … |
2015-3-09 |
2020-12-31 |
|
| ヒト血漿カリクレイン阻害剤 |
2021-7-15 |
2024-2-15 |
2024-2-15 |
| Patent LUC00084I2 |
2018-8-22 |
2018-11-08 |
|
| Compostos inibidores de calicreína de plasma humano |
2016-9-30 |
2023-7-18 |
|